EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, AMBS: Amarantus Bioscience Holdings Inc

24 Nov 2025
LAST:

0.0001

CHANGE:
 0.00		OPEN:
0.0001		HIGH:
0.0002		ASK:
0.0000		VOLUME:
1.84M
CHG(%):
66.67		PREV:
0.0003		LOW:
0.0001		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume

PROFILE

Name:Amarantus Bioscience Holdings Inc
About:Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company's diagnostic products in development include the lymphocyte proliferation (LymPro) test, a diagnostic blood test for Alzheimer's disease; and MSPrecise, a proprietary DNA sequencing assay for the identification of patients with multiple sclerosis. Its therapeutic products in development comprise Eltoprazine, a small molecule drug for the treatment of Parkinson's disease Levadopa-Induced Dyskinesia and attention deficit hyperactivity disorders; and mesencephalic-astrocyte-derived neurotrophic factor for the treatment of various animal models, including retinitis pigmentosa and retinal artery occlusion. It also develops NuroPro, a neurodegenerative disease diagnostic platform with application in Parkinson's disease; BC-SeraPro, an oncology diagnostic platform with application in breast cancer; and PhenoGuard platform for neurrotrophic factor discovery. In addition, the company develops Engineered Skin Substitute (ESS), a cell therapy-based autologous skin replacement product that is in mid-stage clinical development for the treatment of life-threatening severe burns. Amarantus BioScience Holdings, Inc. has a cooperative research and development agreement with the U.S. Army Institute of Surgical Research and Rutgers University. The company was formerly known as Amarantus Bioscience, Inc. and changed its name to Amarantus BioScience Holdings, Inc. in April 2013. Amarantus BioScience Holdings, Inc. was founded in 2008 and is headquartered in New York, New York.
Sector:Healthcare
Industry:Biotechnology
Address:45 Wall Street, New York, NY, United States, 10005
Website:https://www.amarantus.com
CUSIP:02300U205
CIK:0001424812
ISIN:US02300U2050
FIGI:BBG000BDBYQ3

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.000.0%
MA10:0.00100.0%
MA20:0.00100.0%
RSI14:50.00
WPR14:-100.00 
MTM14:0.00
ROC14:-0.75 
ATR:0.00 
Week High:0.00100.0%
Week Low:0.000.0%
Month High:0.00100.0%
Month Low:0.00